Novartis Stock (NYSE: NVS) stock price, news, charts, stock research, profile.
Open | $93.200 |
Close | $94.360 |
Volume / Avg. | 2.338M / 1.487M |
Day Range | 93.150 - 94.495 |
52 Wk Range | 92.190 - 108.780 |
Market Cap | $192.875B |
P/E Ratio | 22.578 |
Dividend Yield | 4.080% |
Exchange | NYSE |
RSI | 43 |
Short Interest | 0.21% |
Days to Cover | 2.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Novartis (NYSE: NVS) through any online brokerage.
Other companies in Novartis’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
The latest price target for Novartis (NYSE: NVS) was reported by BMO Capital on Friday, February 23, 2024. The analyst firm set a price target for 114.00 expecting NVS to rise to within 12 months (a possible 20.81% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Novartis (NYSE: NVS) is $94.36 last updated April 19, 2024 at 4:00 PM EDT.
A quarterly cash dividend of $1.21 per share of Class A Common Stock. The quarterly cash dividend was payable on March 20, 2023 to stockholders of record on March 9, 2023.
Novartis’s Q2 earnings are confirmed for Tuesday, July 16, 2024.
There is no upcoming split for Novartis.
Novartis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.